- Home
- SELF vs ABVC Comparison
SELF vs ABVC Comparison
Compare SELF & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | ABVC |
|---|---|---|
| Founded | 1983 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8M | 58.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SELF | ABVC |
|---|---|---|
| Price | $5.07 | $2.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 44.2K | ★ 66.1K |
| Earning Date | 11-07-2025 | 11-03-2025 |
| Dividend Yield | ★ 5.72% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $12,733,279.00 | $797,916.00 |
| Revenue This Year | $1.59 | $735.18 |
| Revenue Next Year | $1.62 | N/A |
| P/E Ratio | $31.63 | ★ N/A |
| Revenue Growth | 3.36 | ★ 56.52 |
| 52 Week Low | $4.73 | $0.40 |
| 52 Week High | $5.89 | $5.48 |
Technical Indicators
Market Signals| Indicator | SELF | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | 50.71 | 39.20 |
| Support Level | $5.02 | $1.96 |
| Resistance Level | $5.15 | $2.12 |
| Average True Range (ATR) | 0.10 | 0.15 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 37.14 | 17.17 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.